文献速递心脑血管急症

急诊科胸痛患者临床HEART评分一致性、准确性与依从性的前瞻性评估

A Prospective Evaluation of Clinical HEART Score Agreement, Accuracy, and Adherence in Emergency Department Chest Pain Patients.
PubMed 文献 · Ann Emerg Med · 2021-06-18
一句话结论急诊临床HEART评分与科研评分仅中度一致(κ=0.48),作者呼吁谨慎将其作为急诊处置的唯一决定因素。

本研究在单中心前瞻性纳入336例疑似急性冠脉综合征的成人急诊患者,比较临床医生在接诊时记录的HEART评分与研究人员独立访谈生成的HEART评分之间的一致性,并评估两者对30天主要不良心脏事件的预测准确性。结果显示二分类HEART评分一致率为78%(κ=0.48),病史和心电图成分一致性最低;临床医生评分的敏感性为100%,特异性为27.8%,而科研评分敏感性为86.7%,特异性为34.6%。4例科研HEART评分低的患者发生了主要不良心脏事件。作者认为临床与科研HEART评分仅中度一致,结合预测准确性的不确定性,呼吁谨慎将HEART评分作为急诊处置的唯一决定因素。

要点

  • 临床HEART评分与科研评分二分类一致率为78%,κ=0.48(95%CI 0.37-0.58),PABAK=0.57(95%CI 0.48-0.65),仅为中度一致。
  • 一致性最低的成分为病史(一致率72%,加权κ=0.14,95%CI 0.06-0.22)和心电图(一致率85%,加权κ=0.4,95%CI 0.3-0.49)。
  • 临床医生评分对30天主要不良心脏事件的敏感性为100%(95%CI 88.4%-100%),特异性为27.8%(95%CI 22.8%-33.2%)。
  • 科研评分敏感性为86.7%(95%CI 69.3%-96.2%),特异性为34.6%(95%CI 29.3%-40.3%)。
  • 4例科研HEART评分低的患者发生了主要不良心脏事件,作者呼吁谨慎将HEART评分作为急诊处置的唯一决定因素。

适用人群与场景

  • 单中心前瞻性纳入的成人急诊患者,症状疑似急性冠状动脉综合征。

研究设计与关键结果

  • 研究类型为前瞻性评估,单中心,2016年11月至2019年6月共纳入336例患者,261例(77.7%)被收住院,30例(8.9%)发生30天主要不良心脏事件。
  • 二分类HEART评分一致率为78%(κ=0.48,95%CI 0.37-0.58;PABAK=0.57,95%CI 0.48-0.65)。
  • 病史成分一致率72%(加权κ=0.14,95%CI 0.06-0.22),心电图成分一致率85%(加权κ=0.4,95%CI 0.3-0.49)。
  • 临床医生评分 vs 科研评分:敏感性100%(95%CI 88.4%-100%)vs 86.7%(95%CI 69.3%-96.2%);特异性27.8%(95%CI 22.8%-33.2%)vs 34.6%(95%CI 29.3%-40.3%)。
  • 4例科研HEART评分低的患者发生主要不良心脏事件。

证据类型、等级与局限

  • 证据类型:单中心前瞻性评估。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,临床与科研HEART评分仅中度一致,结合预测主要不良心脏事件准确性的不确定性,呼吁谨慎将HEART评分作为急诊处置的唯一决定因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: The HEART score is a risk stratification aid that may safely reduce chest pain admissions for emergency department patients. However, differences in interpretation of subjective components potentially alters the performance of the score. We compared agreement between HEART scores determined during clinical practice with research-generated scores and estimated their accuracy in predicting 30-day major adverse cardiac events.

METHODS: We prospectively enrolled adult ED patients with symptoms concerning for acute coronary syndrome at a single tertiary center. ED clinicians submitted their clinical HEART scores during the patient encounter. Researchers then independently interviewed patients to generate a research HEART score. Patients were followed by phone and chart review for major adverse cardiac events. Weighted kappa; unweighted Cohen's kappa; prevalence-adjusted, bias-adjusted kappa (PABAK); and test probabilities were calculated.

RESULTS: From November 2016 to June 2019, 336 patients were enrolled, 261 (77.7%) were admitted, and 30 (8.9%) had major adverse cardiac events. Dichotomized HEART score agreement was 78% (kappa 0.48, 95% confidence interval [CI] 0.37 to 0.58; PABAK 0.57, 95% CI 0.48 to 0.65) with the lowest agreement in the history (72%; WK 0.14, 95% CI 0.06 to 0.22) and electrocardiogram (85%; WK 0.4, 95% CI 0.3 to 0.49) components. Compared with researchers, clinicians had 100% sensitivity (95% CI 88.4% to 100%) (versus 86.7%, 95% CI 69.3% to 96.2%) and 27.8% specificity (95% CI 22.8% to 33.2%) (versus 34.6%, 95% CI 29.3% to 40.3%) for major adverse cardiac events. Four participants with low research HEART scores had major adverse cardiac events.

CONCLUSION: ED clinicians had only moderate agreement with research HEART scores. Combined with uncertainties regarding accuracy in predicting major adverse cardiac events, we urge caution in the widespread use of the HEART score as the sole determinant of ED disposition.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Soares WE, Knee A, Gemme SR, et al. A Prospective Evaluation of Clinical HEART Score Agreement, Accuracy, and Adherence in Emergency Department Chest Pain Patients. Ann Emerg Med. 2021. PMID: 34148661. doi:10.1016/j.annemergmed.2021.03.024

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。